R&Q Insurance Holdings Ltd
Appointment of Non-Executive Directors
19 April 2024
R&Q Insurance Holdings Ltd (AIM-RQIH) ("R&Q" or the "Group") announces the appointments to the Board of Stephen Welch and Lawrence Hirsh as Non-Executive Directors, effective from 18 April 2024.
Stephen Welch has worked for financial sponsors and investors in both executive and non-executive roles. He has extensive experience managing complex corporate issues, including several restructuring situations of regulated financial services and insurance businesses. Stephen is also a Non-Executive Director of Telegraph Media Group Limited, The Spectator (1828) Limited and the Primary Group Limited. Stephen was a partner at McGrathNicol and a Senior Managing Director at FTI Consulting, and is a Chartered Accountant.
Lawrence Hirsh has acted as an independent board member and advisor to a number of companies, providing financial and operational services. Lawrence was previously a Managing Director for Alvarez & Marsal, leading its Southeastern US Corporate Restructuring Practice, and a Partner at Arthur Andersen LLP. As both an advisor and during his career, Lawrence has a track-record of helping drive operational improvements and cost reduction programs.
Jeff Hayman, Chairman of R&Q, said: "Stephen and Lawrence both bring relevant additional experience to the Board, in particular with regards to our priorities of reducing debt and improving the efficiency and expense base of the go-forward business. As we continue to work towards completing the sale of Accredited, these appointments also support our ongoing discussions with lenders to achieve their necessary approvals."
Regulatory disclosure - The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:
Lawrence Randall Hirsh, aged 61, holds no ordinary shares or options in the Company. Lawrence Hirsh's current and previous directorships are as follows:
Current Partnerships / Directorships |
Previous Partnerships / Directorships (last 5 years) |
|||||||||||||||||||||||||||
|
|
In his role as a restructuring advisor at Alverez and Marshall, Lawrence Hirsh was on the board of the following companies at the time of the following insolvency processes:
· American Physician Partners - Chapter 11 in 2023
· Vondrehle Corporation - Receiver appointed in 2023
· Product quest manufacturing - Chapter 11 2018
Stephen Hamilton Welch, aged 50, holds no ordinary shares or options in the Company. Stephen Welch's current and previous directorships are as follows:
Current Partnerships / Directorships |
Previous Partnerships / Directorships (last 5 years) |
|||||||||||||||||||||||||||||||||||||||||||||
|
|
In his role as a restructuring advisor, Stephen Welch was on the board of the following companies at the time of their insolvency processes:
· ABS Limited - solvent scheme of arrangement
· Bakeholdco 1, 2, 3 & 4 - creditors voluntary winding up in 2015
In addition, following the sale of the
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
-Ends-
Enquiries to:
R&Q Insurance Holdings Ltd Jeff Hayman William Spiegel Tom Solomon
|
Tel: +44 (0)20 7780 5850 |
Fenchurch Advisory Partners LLP (Financial Adviser) Kunal Gandhi Brendan Perkins John Sipp Richard Locke Tihomir Kerkenezov
|
Tel: +44 (0)20 7382 2222 |
Barclays Bank PLC (Financial Adviser and Joint Broker) Gary Antenberg Richard Bassingthwaighte Anusuya Nayar Gupta Grant Bickwit
|
Tel: +44 (0)20 7632 2322 |
Howden Tiger (Financial Adviser) Rob Bredahl Leo Beckham
|
Tel: +44 (0)20 7398 4888 |
Deutsche Numis (Nominated Adviser and Joint Broker) Charles Farquhar Giles Rolls
|
Tel: +44 (0)20 7260 1000 |
FTI Consulting Tom Blackwell
|
Tel: +44 (0)20 3727 1051 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.